Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Seminars in Ophthalmology|March 23, 2021
Uveitis Specialists Harnessing Disruptive Technology during the COVID-19 Pandemic and BeyondDaniel Brill, George PapaliodisRetinal Cases & Brief Reports|February 3, 2023
OCCLUSIVE CYTOMEGALOVIRUS PANUVEITIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANTHyun Jun Kim, Daniel Brill, Gian Paolo GiuliariCurrent Opinion in Ophthalmology|August 2, 2022
Private equity in ophthalmology: lessons from other specialtiesDaniel Brill, Shiming Luo, Jayanth Sridhar, et al.Retina (Philadelphia, Pa.)|November 12, 2024
REAL-WORLD LONG-TERM OUTCOMES OF INTRAVITREAL FARICIMAB IN PREVIOUSLY TREATED CHRONIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONNaveen R Ambati, Adam Leone, Daniel Brill, et al.Ocular Immunology and Inflammation|September 2, 2022
Acute Idiopathic Maculopathy Following SARS-CoV-2 VaccinationIsaac D Bleicher, Daniel Brill, Frances Wu, et al.American Journal of Ophthalmology Case Reports|June 15, 2019
Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone useDaniel Brill, Desiree Albert, Taylor Fields, et al.Retinal Cases & Brief Reports|May 14, 2021
CATASTROPHIC, BILATERAL RETINAL VASCULAR OCCLUSION AFTER INTRAVITREAL BEVACIZUMAB INJECTIONCaleb C Ng, Daniel Brill, Emmett T Cunningham, et al.Retina (Philadelphia, Pa.)|January 22, 2025
THE HETEROGENEOUS PRESENTATIONS OF DE NOVO AND RECURRENT OCULAR INFLAMMATION AFTER COVID-19 VACCINATION : A Multicenter Report and a Review of the LiteratureSruthi Arepalli, Laura Kopplin, Edmund Tsui, et al.Pageof 1